Valion Bio

VBIONasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$1.185 M

$0.29 +3.82%

Close of 7 Aug 2026

Revenue

$780.0K

#3522 by revenue

Earnings

-$8.88M

Loss-making

Shares outstanding

2,877,926

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap

All 28 →

#24Nexalin TechnologyNXL$7.77M
#25ENDRA Life SciencesNDRA$5.71M
#26iTonicITOC$4.91M
#27NuwellisNUWE$4.81M
#28Valion BioVBIO$1.18M

Where these numbers come from

Share counts and financials for Valion Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.